Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Revenue

In the year 2025, Teva Pharmaceutical had annual revenue of $17.26B with 4.32% growth. Teva Pharmaceutical had revenue of $4.71B in the quarter ending December 31, 2025, with 11.40% growth.

• Revenue (ttm): $17.26B
• Revenue Growth: +4.32%
• P/S Ratio: 2.15
• Revenue / Employee: $508,336
• Employees: 33,950
• Market Cap: 36.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	17.26B	714.00M	4.32%
Dec 31, 2024	16.54B	698.00M	4.40%
Dec 31, 2023	15.85B	921.00M	6.17%
Dec 31, 2022	14.93B	-953.00M	-6.00%
Dec 31, 2021	15.88B	-781.00M	-4.69%
Dec 31, 2020	16.66B	-228.00M	-1.35%
Dec 31, 2019	16.89B	-1.38B	-7.57%
Dec 31, 2018	18.27B	-3.58B	-16.39%
Dec 31, 2017	21.85B	-50.00M	-0.23%
Dec 31, 2016	21.90B	2.25B	11.45%
Dec 31, 2015	19.65B	-620.00M	-3.06%
Dec 31, 2014	20.27B	-42.00M	-0.21%
Dec 31, 2013	20.31B	-3.00M	-0.01%
Dec 31, 2012	20.32B	2.01B	10.95%
Dec 31, 2011	18.31B	-	-